Fosun Pharma to pay $240 million for Alma Lasers

Fosun Pharma and Pramerica-Fosun China Opportunity Fund intend to buy a leading Israeli aesthetic medical devices manufacturer.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES